Wealth Immunifires Consulting Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 14-12-2024
- Paid Up Capital ₹ 0.10 M
as on 14-12-2024
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 13.91%
(FY 2022)
- Profit -39.55%
(FY 2022)
- Ebitda -39.55%
(FY 2022)
- Net Worth 7.11%
(FY 2022)
- Total Assets -62.95%
(FY 2022)
About Wealth Immunifires Consulting
The Company is engaged in the Professional Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sachin Habib, Amar Itangi, Savita Mokashi, and Seven other members serve as directors at the Company.
- CIN/LLPIN
U74140PN2020PTC193729
- Company No.
193729
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Sep 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Wealth Immunifires Consulting?
Board Members(10)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sachin Habib  | Director | 12-Jan-2024 | Current |
| Amar Itangi | Director | 12-Jan-2024 | Current |
| Savita Mokashi | Director | 07-Sep-2020 | Current |
| Avantika Pusavale | Director | 07-Sep-2020 | Current |
| Sarita Doshi | Director | 07-Sep-2020 | Current |
| Paresh Mokashi | Director | 01-Dec-2022 | Current |
Financial Performance of Wealth Immunifires Consulting.
Wealth Immunifires Consulting Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 13.91% increase. The company also saw a substantial fall in profitability, with a 39.55% decrease in profit. The company's net worth moved up by a moderate rise of 7.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Wealth Immunifires Consulting?
Unlock access to Wealth Immunifires Consulting's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Lead365 Biz Solutions Private LimitedActive 5 months 1 dayParesh Mokashi, Pratik Doshi and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Wealth Immunifires Consulting?
Wealth Immunifires Consulting has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Wealth Immunifires Consulting, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wealth Immunifires Consulting's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
